78091167 - SPIN SIGNAL

Information

  • Trademark
  • 78091167
  • Serial Number
    78091167
  • Filing Date
    November 01, 2001
    23 years ago
  • Transaction Date
    July 22, 2011
    13 years ago
  • Status Date
    March 12, 2006
    18 years ago
  • Published for Opposition Date
    December 17, 2002
    22 years ago
  • Location Date
    September 16, 2005
    19 years ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    HARDY LUDLOW, TARAH KI
  • Attorney Name
    Catherine Mennenga
    Law Office Assigned Location Code
    M10
  • Owners
Mark Drawing Code
1000
Mark Identification
SPIN SIGNAL
Case File Statements
  • GS0011: Chemicals, biochemicals and reagents for use in industry, science, and research, namely, nucleotides, fluorescent nucleotides, oligonucleotides, peptides, proteins, amino acids, organic molecules, chemical markers for DNA and RNA synthesis; reagents for luminescence; reagents for gene expression quantification; reagents for use with the polymerase reaction, PCR, process and RCA, rolling circle amplication process; reagents for cDNA cloning vectors, modifying and restriction enzymes; reagents for labeling, sequencing and fragment analysis of nucleic acids, proteins and custom synthesis; reagents for recombinant protein expression purification, chromatography media, electrophoresis, spectrophotometry and fluorometry; radiochemicals; scintillation assays; and high through put screening assays for drug development; chemical preparations and substances for use in the manufacture of pharmaceutical products; diagnostic preparations and substances for scientific and research use; chemical test reagents, saline solution and reagent-coated paper all for scientific and laboratory use; fissionable chemical elements; radioactive elements, isotopes, preparations, and reagents for industrial, scientific, and research purposes; kits consisting primarily of chemical preparations and reagents for analysis and diagnosis used for scientific purposes, namely, cell separation and culture, nucleic acid purification; radionuclides; and gases and gas mixtures for industrial, scientific, and research purposes
  • GS0051: Contrast media for medical imaging; diagnostic scanning agents, gases and gas mixtures for medical imaging, and reagents for in vivo clinical use; radiopharmaceutical products, namely, radioactive compounds for use in diagnostic imaging for clinical, medical, scientific, and research use; radioactive sources and standards, namely, radioisotope brachytherapy sources and radioactive compounds for use as calibration standards for use in nuclear medicine; radioactive pharmaceutical preparations and non-radioactive reagents for producing radiopharmaceuticals for in vivo diagnostic and therapeutic use; pharmaceutical preparations, namely, reagents for use in medical diagnosis; pre-filled vials containing medical diagnostic reagents; pre-filled cartridges containing saline solution
  • GS0091: Scientific apparatus and instruments for use in measuring, monitoring and surveying, namely, computers, printers, and computer software programs for use in life science research and data analysis, namely, detecting and monitoring radiation, radioactivity, and radioactive contamination, and for nuclear cardiology and medical imaging, for use by laboratories; radiology apparatus and instruments for the reading and interpretation of autoradiographs and films, namely, automated film readers and scanners; apparatus for electrophoresis comprised of gel separation units, power/control units, gel cassettes, tanks, and casting, running and blotting modules; chromatography columns and pumps; scientific apparatus for microfabrication comprised of scanners and imagers; apparatus for scintillation imaging cameras and scintillation counters; synthesis and purification integrated systems comprised of chromatography monitors, computer hardware and data processing software for use in radiology; imaging apparatus for radioactive and luminescent emissions for use in radiology; imaging apparatus for radioactive and luminescent emissions for use in radiology; apparatus for use in the manufacturing of oligonucleotides, comprised of synthesizers and purifiers; apparatus for microarrays, comprised of array spotters, array scanners, slide processors and hybridation buffers; microarray slides; glassware, namely, glass tubes, vials, microvials, and microplates for scientific purposes; and parts and fittings for the aforesaid goods; diagnostic and test kits for medical use comprised of test tubes, test plates and indicator charts for evaluating test results
  • GS0101: Surgical, medical, dental, and veterinary apparatus and instruments used for the purpose of measuring, monitoring and surveying in the field of radiotherapy, namely, medical needles, suture needles, implantable radiation therapy devices and implantable radiation therapy devices consisting of encapsulated radioisotope brachytherapy sources, radiation therapy delivery system consisting primarily of radioactive seeds and a bio-absorbable carrier assembly; radiological apparatus for diagnostic and medical purposes, namely, magnetic resonance imagers, MRI; x-ray apparatus for medical use; x-ray diagnostic apparatus, computerized tomography apparatus, CAT scan apparatus; scanners and ultrasound diagnostic apparatus; cannulas; vial access cannulas; needles and syringes for medical use; injectors for medical use; cartridges for medical use; infusion pumps for intravenous administration of fluids; imaging apparatus for radioactive and luminescent emissions for use in radiology; and parts and fittings for the aforesaid goods
  • GS0411: Educational services, namely training services and conducting classes and seminars in the field of medical imaging and diagnostics; holding seminars, conferences, symposiums and workshops relating to the pharmaceutical industry, for medical practitioners and employees of pharmaceutical companies.
  • GS0421: Pharmaceutical advice, consultancy, and analytical services relating to chemical and pharmaceutical research for pharmaceutical companies in the field of purification and chromatography; development services in the fields of pharmaceuticals, life sciences, medicine and biochemistry; product research and development for others, namely research and development of pharmaceutical, medical, and veterinary preparations, diagnostic media and agents for use in medical and diagnostic imaging; providing medical information and medicinal information, namely, information regarding pharmacological properties to pharmaceutical companies and medical professionals; medical laboratory services, namely, medical diagnostic services, and medical imaging services; radiolabeling services, namely isotopic labeling of biological molecules; pharmaceutical drug development services for pharmaceutical companies and medical professionals
Case File Event Statements
  • 5/17/2006 - 18 years ago
    40 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Type: MAB6
  • 5/17/2006 - 18 years ago
    39 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 9/19/2005 - 19 years ago
    38 - EXTENSION 5 GRANTED Type: EX5G
  • 9/11/2005 - 19 years ago
    37 - EXTENSION 5 FILED Type: EXT5
  • 9/12/2005 - 19 years ago
    36 - TEAS EXTENSION RECEIVED Type: EEXT
  • 9/12/2005 - 19 years ago
    35 - TEAS EXTENSION RECEIVED Type: EEXT
  • 4/4/2005 - 19 years ago
    34 - EXTENSION 4 GRANTED Type: EX4G
  • 3/8/2005 - 19 years ago
    33 - EXTENSION 4 FILED Type: EXT4
  • 3/8/2005 - 19 years ago
    32 - TEAS EXTENSION RECEIVED Type: EEXT
  • 2/17/2005 - 19 years ago
    31 - ATTORNEY REVOKED AND/OR APPOINTED Type: ARAA
  • 2/17/2005 - 19 years ago
    30 - TEAS REVOKE/APPOINT ATTORNEY RECEIVED Type: REAP
  • 9/23/2004 - 20 years ago
    29 - EXTENSION 3 GRANTED Type: EX3G
  • 9/11/2004 - 20 years ago
    28 - EXTENSION 3 FILED Type: EXT3
  • 9/13/2004 - 20 years ago
    27 - TEAS EXTENSION RECEIVED Type: EEXT
  • 8/24/2004 - 20 years ago
    26 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 8/11/2004 - 20 years ago
    25 - CASE FILE IN TICRS Type: CFIT
  • 2/4/2004 - 20 years ago
    24 - EXTENSION 2 GRANTED Type: EX2G
  • 1/12/2004 - 21 years ago
    23 - EXTENSION 2 FILED Type: EXT2
  • 1/12/2004 - 21 years ago
    22 - TEAS EXTENSION RECEIVED Type: EEXT
  • 9/22/2003 - 21 years ago
    21 - PAPER RECEIVED Type: MAIL
  • 9/2/2003 - 21 years ago
    20 - EXTENSION 1 GRANTED Type: EX1G
  • 8/7/2003 - 21 years ago
    19 - EXTENSION 1 FILED Type: EXT1
  • 8/7/2003 - 21 years ago
    18 - PAPER RECEIVED Type: MAIL
  • 4/1/2003 - 21 years ago
    17 - PAPER RECEIVED Type: MAIL
  • 3/11/2003 - 21 years ago
    16 - NOA MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 12/18/2002 - 22 years ago
    15 - PAPER RECEIVED Type: MAIL
  • 12/17/2002 - 22 years ago
    14 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 11/27/2002 - 22 years ago
    13 - NOTICE OF PUBLICATION Type: NPUB
  • 10/17/2002 - 22 years ago
    12 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 10/17/2002 - 22 years ago
    11 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 10/15/2002 - 22 years ago
    10 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/15/2002 - 22 years ago
    9 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX
  • 8/9/2002 - 22 years ago
    8 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/15/2002 - 22 years ago
    7 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/15/2002 - 22 years ago
    6 - PAPER RECEIVED Type: MAIL
  • 5/17/2002 - 22 years ago
    5 - FINAL REFUSAL E-MAILED Type: GNFR
  • 4/5/2002 - 22 years ago
    4 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/5/2002 - 22 years ago
    3 - PAPER RECEIVED Type: MAIL
  • 2/9/2002 - 22 years ago
    2 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 1/30/2002 - 22 years ago
    1 - ASSIGNED TO EXAMINER Type: DOCK